Detalhe da pesquisa
1.
Statistical controversies in clinical research: should schedules of tumor size assessments be changed?
Ann Oncol
; 27(11): 1981-1987, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502711
2.
How to report toxicity associated with targeted therapies?
Ann Oncol
; 27(8): 1633-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27217543
3.
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO).
Ann Oncol
; 26(10): 2168-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202596
4.
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.
Br J Cancer
; 109(10): 2574-8, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149182
5.
Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
Eur J Surg Oncol
; 43(4): 689-695, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889197